Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 501–600 of 2,883
Manzella, N., Santin, Y., Maggiorani, D., Martini, H., Douin‐Echinard, V., Passos, J. F., Lezoualc'h, F., Binda, C., Parini, A., & Mialet‐Perez, J. (2018) · Aging Cell · doi:10.1111/acel.12811 · Cited by 106
Oxidative stress, aging, antioxidant supplementation and their impact on human health: An overview
Martemucci, G., Portincasa, P., Ciaula, A. D., Mariano, M., Centonze, V., & D‘Alessandro, A. G. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111707 · Cited by 120
Detecting and targeting senescent cells using molecularly imprinted nanoparticles
Ekpenyong-Akiba, A. E., Canfarotta, F., Abd H., B., Poblocka, M., Casulleras, M., Castilla-Vallmanya, L., Kocsis-Fodor, G., Kelly, M. E., Janus, J., Althubiti, M., et al. (2019) · Nanoscale Horizons · doi:10.1039/c8nh00473k · Cited by 108
Yan, P., Li, Z., Xiong, J., Geng, Z., Wei, W., Zhang, Y., Wu, G., Zhuang, T., Tian, X., Liu, Z., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110038 · Cited by 122
Targeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 105
Regulation of inflammation as an anti‐aging intervention
Neves, J., & Sousa‐Victor, P. (2019) · FEBS Journal · doi:10.1111/febs.15061 · Cited by 119
The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype
Wallis, R., Mizen, H., & Bishop, C. L. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111263 · Cited by 108
Quiescence: Good and Bad of Stem Cell Aging
Tümpel, S., & Rudolph, K. L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.05.002 · Cited by 115
Scarless wound healing: From development to senescence
Pratsinis, H., Mavrogonatou, E., & Kletsas, D. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.011 · Cited by 103
Role of cellular senescence in inflammation and regeneration
Saito, Y., Yamamoto, S., & Chikenji, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00342-5 · Cited by 140
How good is the evidence that cellular senescence causes skin ageing?
Low, E., Alimohammadiha, G., Smith, L. A., Costello, L. F., Przyborski, S. A., von Zglinicki, T., & Miwa, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101456 · Cited by 106
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
Owens, W. A., Walaszczyk, A., Spyridopoulos, I., Dookun, E., & Richardson, G. D. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111540 · Cited by 122
Emerging senolytic agents derived from natural products
Li, W., Qin, L., Feng, R., Hu, G., Sun, H., He, Y., & Zhang, R. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.05.001 · Cited by 105
Ritschka, B., Knauer-Meyer, T., Gonçalves, D. S., Mas, A., Plassat, J.-L., Durik, M., Jacobs, H., Pedone, E., Di Vicino, U., Cosma, M. P., et al. (2020) · Genes & Development · doi:10.1101/gad.332643.119 · Cited by 105
“…such as p16 Ink4a , p19 Arf , and p21, as well as secreting inflammatory factors of the senescence-associated secretory phenotype (SASP), contributes to the loss of tissue function seen during aging and in many disease states (Muñoz-Espín and Serrano 2014; Baker et al. 2016; Childs et al. 2017).”
Self-citationAbdul-Aziz, A. M., Sun, Y., Hellmich, C., Marlein, C. R., Mistry, J., Forde, E., Piddock, R. E., Shafat, M. S., Morfakis, A., Mehta, T., et al. (2019) · Blood · doi:10.1182/blood-2018-04-845420 · Cited by 105
Senescent cells and macrophages: key players for regeneration?
Elder, S. S., & Emmerson, E. (2020) · Open Biology · doi:10.1098/rsob.200309 · Cited by 120
The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies
Toutfaire, M., Bauwens, É., & Debacq‐Chainiaux, F. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.011 · Cited by 120
Wiggins, K. A., Parry, A. J., Cassidy, L. D., Humphry, M., Webster, S. J., Goodall, J. C., Narita, M., & Clarke, M. C. H. (2019) · Aging Cell · doi:10.1111/acel.12946 · Cited by 104
Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Masaldan, S., Belaidi, A. A., Ayton, S., & Bush, A. I. (2019) · Pharmaceuticals · doi:10.3390/ph12020093 · Cited by 102
Caloric restriction and cellular senescence
Fontana, L., Nehme, J., & Demaria, M. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.10.005 · Cited by 104
Adipose tissue as a linchpin of organismal ageing
Nguyen, T., & Corvera, S. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01046-3 · Cited by 127
Genomic Instability and Epigenetic Changes during Aging
López-Gil, L., Pascual-Ahuir, A., & Proft, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814279 · Cited by 104
Metabolic interplays between the tumour and the host shape the tumour macroenvironment
Altea‐Manzano, P., Decker-Farrell, A. R., Janowitz, T., & Erez, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00786-4 · Cited by 150
Systemic Aging Fuels Heart Failure: Molecular Mechanisms and Therapeutic Avenues
Fang, Z., Raza, U., Song, J., Lu, J., Yao, S., Liu, X., Zhang, W., & Li, S. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14947 · Cited by 137
“…preserves cardioprotective channels, reduces hypertrophy and cardiac fi brosis, elevates cardiomyocyte proliferation and thereby extends lifespan, 220,221 highlighting the importance of developing senomorphics and senolytics for HF. Recently, owing to its senomorphic properties, such as altering…”
Cellular senescence and its role in white adipose tissue
Smith, U., Li, Q., Rydén, M., & Spalding, K. L. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00757-x · Cited by 122
Zhang, X., Pearsall, V. M., Carver, C. M., Atkinson, E. J., Clarkson, B. D. S., Grund, E. M., Baez-Faria, M., Pavelko, K. D., Kachergus, J. M., White, T. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33226-8 · Cited by 102
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
Xu, J., Zhou, L., & Liu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.601325 · Cited by 123
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 110
Deletion of SA β‐Gal+ cells using senolytics improves muscle regeneration in old mice
Dungan, C. M., Murach, K. A., Zdunek, C. J., Tang, Z. J., Nolt, G. L., Brightwell, C. R., Hettinger, Z., Englund, D. A., Liu, Z., Fry, C. S., et al. (2022) · Aging Cell · doi:10.1111/acel.13528 · Cited by 102
Conserved senescence associated genes and pathways in primary human fibroblasts detected by RNA-seq
Marthandan, S., Baumgart, M., Priebe, S., Groth, M., Schaer, J., Kaether, C., Guthke, R., Cellerino, A., Platzer, M., Diekmann, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154531 · Cited by 91
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Hubackova, S., Davidova, E., Rohlenova, K., Stursa, J., Werner, L., Andera, L., Dong, L., Terp, M. G., Hodny, Z., Ditzel, H. J., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0118-3 · Cited by 101
The clinical impact and biological mechanisms of skeletal muscle aging
Aversa, Z., Zhang, X., Fielding, R. A., Lanza, I., & LeBrasseur, N. K. (2019) · Bone · doi:10.1016/j.bone.2019.05.021 · Cited by 101
Novais, E. J., Diekman, B. O., Shapiro, I. M., & Risbud, M. V. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.02.004 · Cited by 100
Biological functions of therapy-induced senescence in cancer
Fitsiou, E., Soto-Gamez, A., & Demaria, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.021 · Cited by 111
Principles of the Molecular and Cellular Mechanisms of Aging
da Silva, P. F. L., & Schumacher, B. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.11.018 · Cited by 100
Molecular pathways of senescence regulate placental structure and function
Gal, H., Lysenko, M., Stroganov, S., Vadai, E., Youssef, S. A., Tzadikevitch‐Geffen, K., Rotkopf, R., Biron‐Shental, T., de Bruin, A., Neeman, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100849 · Cited by 99
Role of Nrf2 in cell senescence regulation
Yuan, H., Xu, Y., Luo, Y., Wang, N.-X., & Xiao, J. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03901-9 · Cited by 108
Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease
Johnson, S. C. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_3 · Cited by 110
Chi, C., Fu, H., Li, Y., Zhang, G., Zeng, F., Ji, Q., Shen, Q., Wang, X.-J., Li, Z., Zhou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac431 · Cited by 109
Tarantini, S., Balasubramanian, P., DelFavero, J., Csípő, T., Yabluchanskiy, A., Kiss, T., Nyúl‐Tóth, Á., Mukli, P., Tóth, P., Ahire, C., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00440-z · Cited by 107
Ageing and mesenchymal stem cells derived exosomes: Molecular insight and challenges
Ahmadi, M., & Rezaie, J. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3602 · Cited by 106
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
The Role of Pathological Aging in Cardiac and Pulmonary Fibrosis
Murtha, L. A., Morten, M., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Ngo, D. T., Sverdlov, A. L., Knight, D. A., et al. (2019) · Aging and disease · doi:10.14336/ad.2018.0601 · Cited by 96
Perspective: Targeting the JAK/STAT pathway to fight age-related dysfunction
Xu, M., Tchkonia, T., & Kirkland, J. L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.015 · Cited by 99
“We found that genetic clearance of senescent cells improved adipogenesis in fat tissue in older, naturally-aged mice (20), a finding that was subsequently confirmed by others (39).”
Yoshida, K., COLOGNE, J. B., Cordova, K. A., Misumi, M., Yamaoka, M., Kyoizumi, S., Hayashi, T., Robins, H. S., & Kusunoki, Y. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.05.015 · Cited by 110
Dolgin, E. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-00750-1 · Cited by 102
Fate of microglia during HIV‐1 infection: From activation to senescence?
Chen, N. C., Partridge, A. T., Sell, C., Torres, C., & Martín‐García, J. (2017) · Glia · doi:10.1002/glia.23081 · Cited by 95
Senescent tumor cells: an overlooked adversary in the battle against cancer
Park, S. S., Choi, Y. W., Kim, J., Kim, H. S., & Park, T. J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00717-5 · Cited by 113
Why and how are we living longer?
Kirkwood, T. B. L. (2017) · Experimental Physiology · doi:10.1113/ep086205 · Cited by 95
Castellano, G., Franzin, R., Sallustio, F., Stasi, A., Banelli, B., Romani, M., De Palma, G., Lucarelli, G., Divella, C., Battaglia, M., et al. (2019) · Aging · doi:10.18632/aging.102059 · Cited by 95
DNA Damage: A Main Determinant of Vascular Aging
Bautista‐Niño, P. K., Portilla-Fernández, E., Vaughan, D. E., Danser, A. H. J., & Roks, A. J. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050748 · Cited by 99
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
Pharmacotherapy for knee osteoarthritis: current and emerging therapies
Cao, P., Li, Y., Tang, Y., Ding, C., & Hunter, D. J. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1732924 · Cited by 109
Terlecki-Zaniewicz, L., Pils, V., Bobbili, M. R., Lämmermann, I., Perrotta, I., Grillenberger, T., Schwestka, J., Weiß, K., Pum, D., Arcalis, E., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.015 · Cited by 93
The role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
Englund, D. A., Zhang, X., Aversa, Z., & LeBrasseur, N. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111595 · Cited by 94
The Histone Code of Senescence
Paluvai, H., Di Giorgio, E., & Brancolini, C. (2020) · Cells · doi:10.3390/cells9020466 · Cited by 93
Cellular senescence as a potential mediator of COVID‐19 severity in the elderly
Nehme, J., Borghesan, M., Mackedenski, S., Bird, T. G., & Demaria, M. (2020) · Aging Cell · doi:10.1111/acel.13237 · Cited by 94
ATRX is a regulator of therapy induced senescence in human cells
Kovatcheva, M., Liao, W., Klein, M. E., Robine, N., Geiger, H., Crago, A. M., Dickson, M. A., Tap, W. D., Singer, S., & Koff, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00540-5 · Cited by 89
Extracellular vesicles and aging
Robbins, P. D. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.12.03 · Cited by 93
Latorre, E., Birar, V. C., Sheerin, A. N., Jeynes, J. C. C., Hooper, A., Dawe, H. R., Melzer, D., Cox, L. S., Faragher, R. G. A., Ostler, E. L., et al. (2017) · BMC Cell Biology · doi:10.1186/s12860-017-0147-7 · Cited by 93
Telomeres, Telomerase and Ageing
Saretzki, G. (2018) · Subcellular Biochemistry · doi:10.1007/978-981-13-2835-0_9 · Cited by 93
The role of senescent T cells in immunopathology
Covre, L. P., De Maeyer, R. P. H., Gomes, D. C. O., & Akbar, A. N. (2020) · Aging Cell · doi:10.1111/acel.13272 · Cited by 93
“Transgenic mouse models that enable the specific removal of senescent cells from different tissues in vivo show that the elimination of these cells increases lifespan, improves overall fitness and reduces age-associated characteristics of the animals (Baar et al., 2017; Baker et al., 2011, 2016).”
BackgroundObesity-related kidney disease: Beyond hypertension and insulin-resistance
Arabi, T. Z., Shafqat, A., Sabbah, B. N., Ashraf, N., Shah, H., Abdulkader, H. S., Razak, A., Sabbah, A. N., & Arabi, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1095211 · Cited by 117
Zhao, Y., Tyshkovskiy, A., Muñoz-Espín, D., Tian, X., Serrano, M., de Magalhaes, J. P., Nevo, E., Gladyshev, V. N., Seluanov, A., & Gorbunova, V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721160115 · Cited by 92
Accelerated Kidney Aging in Diabetes Mellitus
Guo, J., Zheng, H. J., Zhang, W., Lou, W., Xia, C., Han, X. T., Huang, W. J., Zhang, F., Wang, Y., & Liu, W. J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1234059 · Cited by 93
Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
Franzin, R., Stasi, A., Fiorentino, M., Stallone, G., Cantaluppi, V., Gesualdo, L., & Castellano, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00734 · Cited by 93
Islet biology, the CDKN2A/B locus and type 2 diabetes risk
Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3967-7 · Cited by 104
Cellular senescence of renal tubular epithelial cells in acute kidney injury
Chen, J., Zhang, H., Yi, X., Dou, Q., Yang, X., He, Y., Chen, J., & Chen, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01831-9 · Cited by 110
“For instance, the speci fi c clearance of p16-positive cells retards tumor progression and diminishes tumor metastasis [50].”
BackgroundZhang, C., Xie, Y., Chen, H., Lv, L., Yao, J., Zhang, M., Xia, K., Feng, X., Li, Y., Liang, X., et al. (2020) · Aging · doi:10.18632/aging.102682 · Cited by 92
Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux
Tai, S., Sun, J., Zhou, Y., Zhu, Z., He, Y., Chen, M., Yang, H., Xiao, Y., Tu, T., Tang, L., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.12.009 · Cited by 106
Senescent cells and the incidence of age‐related diseases
Katzir, I., Adler, M., Karin, O., Mendelsohn‐Cohen, N., Mayo, A., & Alon, U. (2021) · Aging Cell · doi:10.1111/acel.13314 · Cited by 85
Can blocking inflammation enhance immunity during aging?
Chambers, E. S., & Akbar, A. N. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.016 · Cited by 92
“11 | P a g e increased lifespan, improved fitness and reduced fur loss (85, 86).”
BackgroundThe KEAP1-NRF2 System in Healthy Aging and Longevity
Matsumaru, D., & Motohashi, H. (2021) · Antioxidants · doi:10.3390/antiox10121929 · Cited by 93
Programmed cell senescence in skeleton during late puberty
Li, C., Chai, Y., Wang, L., Gao, B., Chen, H., Gao, P., Zhou, F.-Q., Luo, X., Crane, J. L., Yu, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01509-0 · Cited by 92
Hsp90 inhibitors as senolytic drugs to extend healthy aging
Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., & Robbins, P. D. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1475828 · Cited by 92
“mice carrying a p16-INK-ATTAC transgene where a suicide gene is expressed specifically in p16-positive senescent cells [5,6].”
BackgroundEpigenetic Mechanisms Impacting Aging: A Focus on Histone Levels and Telomeres
Song, S., & Johnson, F. B. (2018) · Genes · doi:10.3390/genes9040201 · Cited by 101
G3BP1 controls the senescence-associated secretome and its impact on cancer progression
Omer, A., Cruz-Barrera, M., Moran, J. L., Lian, X. J., Marco, S. D., Beausejour, C. M., & Gallouzi, I. (2020) · Nature Communications · doi:10.1038/s41467-020-18734-9 · Cited by 100
p21 induces a senescence program and skeletal muscle dysfunction
Englund, D. A., Jolliffe, A., Aversa, Z., Zhang, X., Sturmlechner, I., Sakamoto, A. E., Zeidler, J. D., Warner, G. M., McNinch, C., White, T. A., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101652 · Cited by 90
Self-citationDissecting primary and secondary senescence to enable new senotherapeutic strategies
Admasu, T. D., Rae, M. J., & Stolzing, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101412 · Cited by 103
Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms
Beck, J., Turnquist, C., Horikawa, I., & Harris, C. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa071 · Cited by 92
Blasiak, J., Piechota, M., Pawlowska, E., Szatkowska, M., Sikora, E., & Kaarniranta, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5293258 · Cited by 90
Osteoarthritis year in review 2017: biology
Appleton, C. T. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.10.008 · Cited by 108
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon, J., Petit, C., Moreau, M., Toutain, B., Henry, C., Roché, H., Bonichon-Lamichhane, N., Salmon, J. P., Lemonnier, J., Campone, M., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1406-7 · Cited by 90
Age and Sex: Impact on adipose tissue metabolism and inflammation
Varghese, M., Song, J., & Singer, K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111563 · Cited by 111
Poppler, L. H., Ee, X., Schellhardt, L., Hoben, G. M., Pan, D., Hunter, D. A., Yan, Y., Moore, A. M., Snyder‐Warwick, A. K., Stewart, S. A., et al. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0003 · Cited by 96
Sleep and biological aging: A short review
Carroll, J., & Prather, A. A. (2021) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2021.03.021 · Cited by 101
Elyahu, Y., & Monsonego, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101231 · Cited by 103
Biological ageing with HIV infection: evaluating the geroscience hypothesis
Montano, M. A., Oursler, K. K., Xu, K., Sun, Y. V., & Marconi, V. C. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00278-6 · Cited by 110
Bacterial induction of B cell senescence promotes age-related changes in the gut microbiota
Kawamoto, S., Uemura, K., Hori, N., Takayasu, L., Konishi, Y., Katoh, K., Matsumoto, T., Suzuki, M., Sakai, Y., Matsudaira, T., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01145-5 · Cited by 91
Targeting the SASP to combat ageing: Mitochondria as possible intracellular allies?
Birch, J., & Passos, J. F. (2017) · BioEssays · doi:10.1002/bies.201600235 · Cited by 89
Functional heterogeneity in senescence
Kirschner, K., Rattanavirotkul, N., Quince, M. F., & Chandra, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190109 · Cited by 89
Cellular senescence in skeletal disease: mechanisms and treatment
He, X., Hu, W., Zhang, Y., Chen, M., Ding, Y., Yang, H., He, F., Gu, Q., & Shi, Q. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00501-5 · Cited by 109
“In contrast, the transplantation of SnCs into young animals causes age-related disorders (31).”
BackgroundCopper accumulation in senescent cells: Interplay between copper transporters and impaired autophagy
Masaldan, S., Clatworthy, S. A. S., Gamell, C., Smith, Z. M., Francis, P. S., Denoyer, D., Meggyesy, P. M., Fontaine, S. L., & Cater, M. A. (2018) · Redox Biology · doi:10.1016/j.redox.2018.03.007 · Cited by 96
Pharmacological Strategies to Retard Cardiovascular Aging
Alfaras, I., Di Germanio, C., Bernier, M., Csiszar, A., Ungvari, Z., Lakatta, E. G., & de Cabo, R. (2016) · Circulation Research · doi:10.1161/circresaha.116.307475 · Cited by 87
Hou, Q., Huang, J., Zhao, L., Pan, X., Liao, C., Jiang, Q., Lei, J., Guo, F., Cui, J., Guo, Y., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106676 · Cited by 93
Interventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A., Mladenovic Djordjevic, A., Lopez-Contreras, A., Henriques, C. M., Selman, C., Ferreiro, E., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 87
Micheli, L., Bertini, L., Bonato, A., Villanova, N., Caruso, C., Caruso, M., Bernini, R., & Tirone, F. (2023) · Nutrients · doi:10.3390/nu15071767 · Cited by 97
ATF6α regulates morphological changes associated with senescence in human fibroblasts
Druelle, C., Drullion, C., Deslé, J., Martin, N., Saas, L., Cormenier, J., Malaquin, N., Huot, L., Slomianny, C., Bouali, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11505 · Cited by 87
HIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 100
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.